Cox Troy 4

What Happened

• Troy Cox, a director of Standard BioTools, was granted 57,264 restricted stock units (RSUs) on Feb 26, 2026. The grant is reported at $1.17 per share for a total value of $66,999 (approximately $67k). The Form 4 classifies the transaction as an award/grant (code A) rather than an open-market trade.

Key Details

• Transaction date: 2026-02-26; Form 4 filed: 2026-03-02 (filed within the SEC’s two-business-day window, i.e., timely).
• Grant size and price: 57,264 RSUs at $1.17 per share; total reported value $66,999.
• Vesting: RSUs vest 25% on the last day of the last month of each fiscal quarter of 2026 (four quarterly tranches), subject to continued service.
• Consideration: RSUs were issued because the reporting person elected to receive RSUs in lieu of ~$67,000 in cash board fees.
• Shares owned after transaction: Not specified in the filing.
• Transaction code: A = Award/Grant (not a purchase or sale).

Context

• RSUs are compensation that convert to actual shares only as they vest; this type of grant is routine director compensation and does not represent an open-market purchase (a clearer bullish signal) or a sale. The filing is informational and shows compensation expense rather than a direct market bet by the insider.